Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

[Predicting atrial fibrillation through a sinus-rhythm electrocardiogram; useful or not?]

Tieleman RG.

Ned Tijdschr Geneeskd. 2019 Nov 28;163. pii: D4525. Dutch.

PMID:
32073792
2.

Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation - Data from RACE 3.

Nguyen BO, Rienstra M, Hobbelt AH, Tijssen JGP, Smit MD, Tieleman RG, Geelhoed B, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC; RACE 3 Investigators.

Am Heart J. 2020 Jan 10. pii: S0002-8703(19)30345-X. doi: 10.1016/j.ahj.2019.12.005. [Epub ahead of print] No abstract available.

PMID:
32067695
3.

Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.

Kaasenbrood F, Hollander M, de Bruijn SH, Dolmans CP, Tieleman RG, Hoes AW, Rutten FH.

Br J Gen Pract. 2020 Jan 27. pii: bjgp20X708161. doi: 10.3399/bjgp20X708161. [Epub ahead of print]

PMID:
31988084
4.

Nurse-led vs. usual-care for atrial fibrillation.

Wijtvliet EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, Rienstra M, Folkeringa RJ, Bronzwaer P, Elvan A, Elders J, Tukkie R, Luermans JGLM, Van Asselt ADIT, Van Kuijk SMJ, Tijssen JG, Crijns HJGM; RACE 4 Investigators.

Eur Heart J. 2020 Feb 1;41(5):634-641. doi: 10.1093/eurheartj/ehz666.

PMID:
31544925
5.

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

de Jong LA, Groeneveld J, Stevanovic J, Rila H, Tieleman RG, Huisman MV, Postma MJ, van Hulst M.

PLoS One. 2019 Sep 17;14(9):e0222658. doi: 10.1371/journal.pone.0222658. eCollection 2019.

6.

Integrated specialized atrial fibrillation clinics reduce all-cause mortality: post hoc analysis of a randomized clinical trial.

Hendriks JML, Tieleman RG, Vrijhoef HJM, Wijtvliet P, Gallagher C, Prins MH, Sanders P, Crijns HJGM.

Europace. 2019 Aug 7. pii: euz209. doi: 10.1093/europace/euz209. [Epub ahead of print]

PMID:
31390464
7.

Atrial Fibrillation in Africa-An Under-Reported and Unrecognized Risk Factor for Stroke: A Systematic Review.

Jacobs MS, van Hulst M, Adeoye AM, Tieleman RG, Postma MJ, Owolabi MO.

Glob Heart. 2019 Sep;14(3):269-279. doi: 10.1016/j.gheart.2019.04.003. Epub 2019 May 15.

PMID:
31103399
8.

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study.

Weijs B, Dudink EAMP, de Vos CB, Limantoro I, Tieleman RG, Pisters R, Cheriex EC, Luermans JGLM, Crijns HJGM.

Neth Heart J. 2019 Oct;27(10):487-497. doi: 10.1007/s12471-019-1272-z.

9.

Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions.

Jacobs MS, van Hulst M, Campmans Z, Tieleman RG.

Neth Heart J. 2019 Jul;27(7-8):371-377. doi: 10.1007/s12471-019-1267-9.

10.

Pulmonary vein anatomy addressed by computed tomography and relation to success of second-generation cryoballoon ablation in paroxysmal atrial fibrillation.

Mulder BA, Al-Jazairi MIH, Arends BKO, Bax N, Dijkshoorn LA, Sheikh U, Tan ES, Wiesfeld ACP, Tieleman RG, Vliegenthart R, Rienstra M, van Gelder IC, Blaauw Y.

Clin Cardiol. 2019 Apr;42(4):438-443. doi: 10.1002/clc.23163. Epub 2019 Mar 13.

11.

Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.

van der Pol S, Jacobs MS, Meijer K, Piersma-Wichers MG, Tieleman RG, Postma MJ, van Hulst M.

Europace. 2019 May 1;21(5):716-723. doi: 10.1093/europace/euy308.

PMID:
30649301
12.

Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.

De With RR, Rienstra M, Smit MD, Weijs B, Zwartkruis VW, Hobbelt AH, Alings M, Tijssen JGP, Brügemann J, Geelhoed B, Hillege HL, Tukkie R, Hemels ME, Tieleman RG, Ranchor AV, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC.

Europace. 2019 Apr 1;21(4):563-571. doi: 10.1093/europace/euy311.

PMID:
30629160
13.

[Will anticoagulation centres become a DOAC service?]

Tieleman RG.

Ned Tijdschr Geneeskd. 2018 Nov 30;162. pii: D3396. Dutch.

PMID:
30570931
14.

Mobile health: solution or a threat?

Tieleman RG, Hemels MEW.

Neth Heart J. 2019 Jan;27(1):16-17. doi: 10.1007/s12471-018-1206-1. No abstract available.

15.

Integrated care to reduce atrial fibrillation burden: do not underrate the overweight!

Smit MD, Rienstra M, Tieleman RG, Van Gelder IC.

Europace. 2018 Dec 1;20(12):1875-1876. doi: 10.1093/europace/euy137. No abstract available.

PMID:
29912313
16.
18.

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.

Rienstra M, Hobbelt AH, Alings M, Tijssen JGP, Smit MD, Brügemann J, Geelhoed B, Tieleman RG, Hillege HL, Tukkie R, Van Veldhuisen DJ, Crijns HJGM, Van Gelder IC; RACE 3 Investigators.

Eur Heart J. 2018 Aug 21;39(32):2987-2996. doi: 10.1093/eurheartj/ehx739.

PMID:
29401239
19.

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.

Jacobs MS, de Jong LA, Postma MJ, Tieleman RG, van Hulst M.

Eur J Health Econ. 2018 Sep;19(7):957-965. doi: 10.1007/s10198-017-0942-2. Epub 2017 Nov 27.

20.

The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.

van Hulst M, Stevanovic J, Jacobs MS, Tieleman RG, Kappelhoff B, Postma MJ.

J Med Econ. 2018 Jan;21(1):38-46. doi: 10.1080/13696998.2017.1372222. Epub 2017 Sep 7.

PMID:
28836865
21.

Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.

Jacobs MS, van Leent MWJ, Tieleman RG, Jansman FGA, Cao Q, Postma MJ, van Hulst M.

J Med Econ. 2017 Dec;20(12):1231-1236. doi: 10.1080/13696998.2017.1363766. Epub 2017 Aug 22.

PMID:
28766370
22.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
23.

Obey the first recommendation: start screening programmes for atrial fibrillation.

Tieleman RG, Hemels ME.

Europace. 2016 Dec;18(12):1753-1755. doi: 10.1093/europace/euw160. No abstract available.

PMID:
28130372
24.

Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.

Jacobs MS, Kaasenbrood F, Postma MJ, van Hulst M, Tieleman RG.

Europace. 2018 Jan 1;20(1):12-18. doi: 10.1093/europace/euw285.

PMID:
27733465
25.

Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination.

Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG.

Europace. 2016 Oct;18(10):1514-1520. Epub 2016 Feb 6.

26.

Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.

Korenstra J, Wijtvliet EP, Veeger NJ, Geluk CA, Bartels GL, Posma JL, Piersma-Wichers M, Van Gelder IC, Rienstra M, Tieleman RG.

Europace. 2016 Sep;18(9):1319-27. doi: 10.1093/europace/euv397. Epub 2016 Feb 3.

27.

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.

Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M.

J Am Coll Cardiol. 2015 Sep 1;66(9):1000-7. doi: 10.1016/j.jacc.2015.06.1314.

28.

An unexpected response to adenosine.

Ter Maaten JM, Tieleman RG.

Neth Heart J. 2015 Jan;23(1):72-3. doi: 10.1007/s12471-014-0631-z. No abstract available.

29.

An unexpected response to adenosine.

Ter Maaten JM, Tieleman RG.

Neth Heart J. 2015 Jan;23(1):77-8. doi: 10.1007/s12471-014-0632-y. No abstract available.

30.

Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.

Stevanović J, Pompen M, Le HH, Rozenbaum MH, Tieleman RG, Postma MJ.

PLoS One. 2014 Aug 5;9(8):e103974. doi: 10.1371/journal.pone.0103974. eCollection 2014.

31.

Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.

van Breugel HN, Gelsomino S, de Vos CB, Accord RE, Tieleman RG, Lucà F, Rostagno C, Renzulli A, Parise O, Lorusso R, Crijns HJ, Maessen JG.

Int J Cardiol. 2014 Aug 1;175(2):290-6. doi: 10.1016/j.ijcard.2014.05.010. Epub 2014 May 16.

PMID:
24882697
32.

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.

Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R, Hofman C, Houben RP.

Europace. 2014 Sep;16(9):1291-5. doi: 10.1093/europace/euu057. Epub 2014 May 13.

33.

The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.

De Vos CB, Limantoro I, Pisters R, Delhaas T, Schotten U, Cheriex EC, Tieleman RG, Crijns HJ.

Heart Rhythm. 2014 Sep;11(9):1514-21. doi: 10.1016/j.hrthm.2014.04.029. Epub 2014 Apr 21.

PMID:
24768608
34.

Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.

Dinh T, Baur LH, Pisters R, Kamp O, Verheugt FW, Smeets JL, Cheriex EC, Lindeboom JE, Heesen WF, Tieleman RG, Prins MH, Crijns HJ; TIARA investigators.

Heart. 2014 Apr;100(7):563-8. doi: 10.1136/heartjnl-2013-305017. Epub 2014 Jan 31.

PMID:
24488608
35.

Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.

Limantoro I, De Vos CB, Delhaas T, Marcos E, Blaauw Y, Weijs B, Tieleman RG, Pisters R, Schotten U, Van Gelder IC, Crijns HJ.

Heart Rhythm. 2014 Mar;11(3):478-84. doi: 10.1016/j.hrthm.2013.12.010. Epub 2013 Dec 7.

PMID:
24321238
36.

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study.

Alings M, Smit MD, Moes ML, Crijns HJ, Tijssen JG, Brügemann J, Hillege HL, Lane DA, Lip GY, Smeets JR, Tieleman RG, Tukkie R, Willems FF, Vermond RA, Van Veldhuisen DJ, Van Gelder IC.

Neth Heart J. 2013 Jul;21(7-8):354-63. doi: 10.1007/s12471-013-0428-5.

37.

The atrial fibrillation knowledge scale: development, validation and results.

Hendriks JM, Crijns HJ, Tieleman RG, Vrijhoef HJ.

Int J Cardiol. 2013 Sep 30;168(2):1422-8. doi: 10.1016/j.ijcard.2012.12.047. Epub 2013 Jan 8.

PMID:
23305860
38.

The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation.

Weijs B, de Vos CB, Tieleman RG, Peeters FE, Limantoro I, Kroon AA, Cheriex EC, Pisters R, Crijns HJ.

Europace. 2013 Jan;15(1):18-23. doi: 10.1093/europace/eus203. Epub 2012 Jul 10.

PMID:
22782972
39.

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.

Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R, Pison LA, Blaauw Y, Tieleman RG.

Eur Heart J. 2012 Nov;33(21):2692-9. doi: 10.1093/eurheartj/ehs071. Epub 2012 Mar 27. Erratum in: Eur Heart J. 2013 Feb;34(6):408.

PMID:
22453654
40.

The presence of an atrial electromechanical delay in idiopathic atrial fibrillation as determined by tissue Doppler imaging.

Weijs B, de Vos CB, Limantoro I, Cheriex EC, Tieleman RG, Crijns HJ.

Int J Cardiol. 2012 Apr 5;156(1):121-2. doi: 10.1016/j.ijcard.2012.01.024. Epub 2012 Feb 2. No abstract available.

PMID:
22305816
41.

Clinical and echocardiographic correlates of intra-atrial conduction delay.

Weijs B, de Vos CB, Tieleman RG, Pisters R, Cheriex EC, Prins MH, Crijns HJ.

Europace. 2011 Dec;13(12):1681-7. doi: 10.1093/europace/eur261. Epub 2011 Aug 15.

PMID:
21846646
42.

Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot study.

Dinh T, Baur LH, Pisters R, Kamp O, Verheugt FW, Smeets JL, Cheriex EC, Tieleman RG, Prins MH, Crijns HJ; TIARA pilot study group.

Neth Heart J. 2011 May;19(5):214-22. doi: 10.1007/s12471-011-0095-3.

43.

Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational Study.

Folkeringa RJ, Tieleman RG, Maessen JG, Prins MH, Nieuwlaat R, Crijns HJ.

Neth Heart J. 2011 Jan;19(1):17-23. Epub 2010 Dec 16.

44.

Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Hendriks JL, Nieuwlaat R, Vrijhoef HJ, de Wit R, Crijns HJ, Tieleman RG.

Neth Heart J. 2010 Oct;18(10):471-7.

45.

The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines.

Pisters R, van Oostenbrugge RJ, Knottnerus IL, de Vos CB, Boreas A, Lodder J, Prins MH, Crijns HJ, Tieleman RG.

Europace. 2010 Jun;12(6):779-84. doi: 10.1093/europace/euq080. Epub 2010 Mar 26.

PMID:
20348143
46.

Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis.

de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, van den Heijkant AC, Allessie MA, Crijns HJ.

J Am Coll Cardiol. 2010 Feb 23;55(8):725-31. doi: 10.1016/j.jacc.2009.11.040.

47.

An integrated chronic care program for patients with atrial fibrillation: study protocol and methodology for an ongoing prospective randomised controlled trial.

Hendriks JM, de Wit R, Vrijhoef HJ, Tieleman RG, Crijns HJ.

Int J Nurs Stud. 2010 Oct;47(10):1310-6. doi: 10.1016/j.ijnurstu.2009.12.017. Epub 2010 Jan 20.

PMID:
20089253
48.

Is surface ECG a useful surrogate for subcutaneous ECG?

Bellardine Black CL, Stromberg K, van Balen GP, Ghanem RN, Breedveld RW, Tieleman RG.

Pacing Clin Electrophysiol. 2010 Feb;33(2):135-45. doi: 10.1111/j.1540-8159.2009.02616.x. Epub 2009 Nov 18.

PMID:
19930107
49.

Atrial fibrillatory wall motion and degree of atrial remodeling in patients with atrial fibrillation: a tissue velocity imaging study.

De Vos CB, Pison L, Pisters R, Schotten U, Cheriex EC, Prins MH, Delhaas T, Crijns HJ, Tieleman RG.

J Cardiovasc Electrophysiol. 2009 Dec;20(12):1374-81. doi: 10.1111/j.1540-8167.2009.01628.x.

PMID:
19817923
50.

No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

Folkeringa RJ, de Vos C, Pinto YM, Habets J, De Leeuw PW, Tieleman RG, Prins MH, Van Dieijen-Visser M, Crijns HJ.

Int J Cardiol. 2010 Nov 5;145(1):156-8. doi: 10.1016/j.ijcard.2009.07.023. Epub 2009 Aug 26.

PMID:
19712983

Supplemental Content

Loading ...
Support Center